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High-Resolution Structure of the Pleckstrin
Homology Domain of Protein Kinase B/Akt Bound
to Phosphatidylinositol (3,4,5)-Trisphosphate
structure reveals a standard PH domain fold [2], with
seven  strands forming two orthogonal antiparallel 
sheets, which are closed at one end by the C-terminal
 helix. At the other end of the  barrel lie three loops
(VL1–3) that are variable, both in sequence and length, in
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School of Life Sciences presently known PH domain structures [2]. These loops
form a bowl lined with basic residues into whichUniversity of Dundee
Dundee DD1 5EH Ins(1,3,4,5)P4 binds (Figures 1B and 2). The head group
forms specific interactions with these basic residuesScotland
United Kingdom and other side chains, and also with the protein back-
bone. The D1 phosphate forms relatively few interac-
tions but interacts with Arg23 and the backbone nitrogen
of Ile19 (Figure 1B). In contrast, the D3 phosphate inter-Summary
acts with four side chains, Lys14, Arg23, Arg25, and
Asn53. This relatively large number of interactions withThe products of PI 3-kinase activation, PtdIns(3,4,5)P3
this phosphate group likely accounts for PKBPH’s in-and its immediate breakdown product PtdIns(3,4)P2,
ability to bind with PtdIns(4,5)P2, which lacks a D3 phos-trigger physiological processes, by interacting
phate [6, 7]. Similarly, the D4 phosphate makes manywith proteins possessing pleckstrin homology (PH)
interactions with Lys14, Asn53, and Arg86, and thesedomains [1, 2]. One of the best characterized
interactions explain why PKBPH does not bind toPtdIns(3,4,5)P3/PtdIns(3,4)P2 effector proteins is pro-
PtdIns(3)P or PtdIns(3,5)P2 [6, 7] (Figure 1B). Interest-tein kinase B (PKB), also known as Akt [3–5]. PKB
ingly, the D5 phosphate does not interact with any pro-possesses a PH domain located at its N terminus, and
tein atoms in the binding pocket. It is oriented towardthis domain binds specifically to PtdIns(3,4,5)P3 and
the solvent and interacts only with five ordered waterPtdIns(3,4)P2 with similar affinity [6, 7]. Following
molecules. This explains the observation that PKB canactivation of PI 3-kinase, PKB is recruited to the
interact with both PtdIns(3,4)P2 or PtdIns(3,4,5)P3 withplasma membrane by virtue of its interaction with
similar affinity [6, 7].PtdIns(3,4,5)P3/PtdIns(3,4)P2 [8–10]. PKB is then acti-
Comparisons of PKBPH with the structures of thevated by the 3-phosphoinositide-dependent pro-
PH domains of BTK, DAPP1, and GRP1 in complex withtein kinase-1 (PDK1), which like PKB, possesses a
Ins(1,3,4,5)P4 (Figure 1B) show several key differencesPtdIns(3,4,5)P3/PtdIns(3,4)P2 binding PH domain [11,
in the mode of interaction of PKBPH with Ins(1,3,4,5)P412]. Here, we describe the high-resolution crystal
that set it apart from these other PH domains. Firstly,structure of the isolated PH domain of PKB in complex
the Ins(1,3,4,5)P4 molecule in the PKBPH complexwith the head group of PtdIns(3,4,5)P3. The head group
structure is in a different orientation than that observedhas a significantly different orientation and location
in previous Ins(1,3,4,5)P4-PH domain structures, and itcompared to other Ins(1,3,4,5)P4 binding PH domains.
is rotated approximately 45 in the plane of the inositolMutagenesis of the basic residues that form ionic in-
ring with respect to the orientation of the ligand in BTK,teractions with the D3 and D4 phosphate groups re-
GRP1, and DAPP1 (Figure 1B). Secondly, the inositolduces or abolishes the ability of PKB to interact with
ring appears to be shifted approximately 4 A˚ towardPtdIns(3,4,5)P3 and PtdIns(3,4)P2. The D5 phosphate
the core of the PH domain compared to the otherfaces the solvent and forms no significant interactions
Ins(1,3,4,5)P4 complexes. As a result of these differ-with any residue on the PH domain, and this explains
ences, there is a shift in the positioning of the phos-why PKB interacts with similar affinity with both
phates and hence a difference in the number and typePtdIns(3,4,5)P3 and PtdIns(3,4)P2.
of interactions/contacts that are formed between the
Ins(1,3,4,5)P4 molecule and the pocket. The D5 phos-Results and Discussion phate and D6 hydroxyl group in the PKBPH complex
are completely solvent exposed and are therefore inca-
Overall Structure and Interaction with pable of forming the hydrogen bonds seen in the other
Ins(1,3,4,5)P4 structures between the D5 phosphate and the backbone
The structure of the pleckstrin homology domain of pro- of VL1. Overall, PKBPH appears to form fewer interac-
tein kinase B (PKBPH) complexed to Ins(1,3,4,5)P4 was tions with Ins(1,3,4,5)P4 than the other PH domains, and
solved by selenomethionine-MAD and yielded experi- this may account for the 10-fold lower affinity of PKBPH
mental phases to 1.4 A˚ resolution (Figure 1). Refine- for Ins(1,3,4,5)P4 compared to DAPP1, BTK, or GRP1
ment of the structure resulted in a complete model for [11–13]. Another significant difference is that most of
residues 1–113 (Figure 1). Well-defined density for the residues that form key interactions between the PH
Ins(1,3,4,5)P4 allowed the construction of a model for this domain and the D3 and D4 phosphates of Ins(1,3,4,5)P4
ligand in the binding pocket (Figure 1). The PKBPH are conserved; BTK, GRP1, and DAPP1 possess a con-
served tyrosine residue (Tyr195 DAPP1, Tyr245 GRP1,
Tyr39 BTK) within the binding site that interacts with3 Correspondence: dava@davapc1.bioch.dundee.ac.uk
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Figure 1. Structure of PKBPH Complexed to Ins(1,3,4,5)P4
(A) A ribbon drawing of the PKBPH-Ins(1,3,4,5)P4 complex, with the seven  strands (labeled 1–7) shown in blue and the  helices (labeled
1–2) shown in red. Ins(1,3,4,5)P4 is shown as purple carbons. The side chains of residues interacting with this molecule are shown as gray
carbons. The basic residues thought to interact with the membrane have their side chains shown as sticks with green carbons. The negatively
charged residues on VL2 that are hypothesized to interact with the kinase domain are shown as gray-blue carbons.
(B) Ribbon diagrams of the Ins(1,3,4,5)P4 binding sites of PKB, GRP1, DAPP1, and BTK. The Ins(1,3,4,5)P4 is shown as purple carbons. For
the PKB-Ins(1,3,4,5)P4 structure, the experimental electron density map from SOLVE after density modification is shown in orange (contoured
at 2.25). Residues that are hydrogen bonding the ligand are shown as sticks with gray carbons. Hydrogen bonds are shown as black dotted
lines.
Current Biology
1258
significantly impaired the activation of PKB in PDGF-
stimulated NIH3T3 cells [9]. This would be in agreement
with Arg15 playing a key role in enabling PKB to interact
with the membrane surface. In addition, in our model of
how the PKB PH domain is oriented relative to the
plasma membrane (Figures 1 and 2), the D1 phosphate
is pointing down toward the membrane, and this orienta-
tion allows for binding of the inositol head group; how-
ever, the di-acyl glycerol backbone is still embedded in
the hydrophobic core of the lipid bilayer, as would be
expected for a PH domain-membrane interaction. This
mode of interaction of the PH domain of PKB with
PtdIns(3,4,5)P3 at the plasma membrane results in two
of the variable loops, VL2 and VL3, pointing away from
the membrane, and this configuration provides possible
docking sites for the PKB kinase domain that are free
of steric hindrance from the membrane surface (Figures
1 and 2). VL3 (Figure 1A) forms a relatively short loop
carrying uncharged side chains. In contrast, VL2 con-
tains a high concentration of negatively charged resi-
dues (Glu40, Asp44, Asp46, and Glu49, Figures 1 and
Figure 2. Charge Distribution
2). This loop also contains a short  helix (Figure 1A),
Electrostatic surface potential of PKBPH-Ins(1,3,4,5)P4 (calculated and the charged residues occupy one side of the helixwith GRASP), with the molecule in the same orientation as in Figure
and face away from the PH domain core, toward the1. Blue areas (6kT) represent highly positively charged residues,
solvent. A short  helix is observed in a similar locationand the red areas (6kT) represent highly negatively charged resi-
dues. Ins(1,3,4,5)P4 is shown as a stick model. in the spectrin PH domain, both in the presence and
absence of a head group [14, 15].
the D4 phosphate, which is not conserved in PKBPH
(Figure 3). The change in head group orientation and Mutagenesis of Residues in the Binding Pocket
The structure indicates that it is the interaction of PKBthe absence of the tyrosine may provide key handles
on the development of PKBPH-specific inhibitors that with the D3 and D4 phosphate groups of the inositol
ring that is the key determinant for the binding ofdo not interact with other PH domains.
Analysis of the electrostatic surface potential of the PtdIns(3,4,5)P3 or PtdIns(3,4)P2 to PKBPH. To further
investigate the molecular basis of the lipid binding speci-PKBPH-Ins(1,3,4,5)P4 complex shows that, apart from
the phosphoinositide binding pocket, there is an addi- ficity of the PH domain, we constructed several full-
length PKB variants with mutations in the lipid bindingtional area of clustered basic residues (Arg15, Lys20,
Arg67, and Arg69) that do not participate in PtdIns bind- pocket and evaluated their interaction with PtdIns(3,4)P2
or PtdIns(3,4,5)P3 using the protein-lipid overlay assaying. These residues form a flat, highly positively charged
surface that could interact with the negatively charged that has been used previously to assess the lipid binding
properties of PKB and other PH domain-containing pro-lipid membrane (Figure 2). In a previous study, Tsichlis
and colleagues observed that mutation of Arg15 to Ala teins [16–18] (Figure 4A). As reported previously, full-
Figure 3. Structure-Based Sequence Alignment
The alignment of four PtdIns(3,4,5)P3 binding PH domains, constructed by superposition of their structures with the MOTIF option in WHAT
IF [31]. Conserved residues are shown in black. Homologous residues are highlighted in gray. The secondary structure is shown as black
arrows for  strands and as bars for the  helices. Helix 1 is shown as a shaded bar. The arrows indicate residues in PKBPH that interact
with the lipid head group. Variable loops 1, 2, and 3 are labeled as VL1, VL2, and VL3, respectively.
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Figure 4. Mutant Analysis
(A) The ability of the wild-type and mutant GST-PKB fusion proteins to bind to the indicated amounts of PtdIns(3,4,5)P3/PtdIns(3,4)P2 was
analyzed by using a protein lipid overlay assay [30].
(B) The ability of PDK1 to activate and phosphorylate the wild-type and mutant PKB. The indicated forms of PKB were incubated with PDK1
magnesium and [32P]ATP in the presence () or absence () of lipid vesicles containing PtdIns(3,4,5)P3 as described previously [11]. The
activation of PKB was assessed by its ability to phosphorylate the peptide substrate Crosstide (GRPRTSSFAEG). Phosphorylation of the AGC
kinase substrate was determined following electrophoresis on a 4%–12% gradient polyacrylamide gel. The Coomassie blue-stained bands
corresponding to each substrate were analyzed by autoradiography of the gel. Under the conditions used, phosphorylation of each substrate
by PDK1 was linear with time and with the amount of enzyme added to the assay. Experiments were performed in duplicate, and similar
results were obtained in two separate experiments.
length PKB interacted with both PtdIns(3,4,5)P3 and duced affinity compared to the wild-type PKB mutant,
and this indicates that the observed interaction of Arg23PtdIns(3,4)P2, but a mutant lacking the entire PH domain
(PH-PKB) did not detectably interact with these phos- with the D1 phosphate (Figures 1 and 3) plays a role in
regulating the overall affinity of PKB for 3-phosphoinosi-phoinositides (Figure 4). The affinity of PKB for the D1
phosphate was addressed by mutating Arg23 to Ala. tides.
A more dramatic effect is observed when Arg25 (whichThe PKB[R23A] was still capable of interacting with
both PtdIns(3,4,5)P3 and PtdIns(3,4)P2, albeit with re- binds the D3 phosphate, Figures 1 and 3) is mutated to
Table 1. Details of Data Collection and Structure Refinement for a MAD Data Set Collected on PKBPH-Ins(1,3,4,5)P4 Crystals
Structure Peak Inflection Remote
Wave Length (A˚) 0.97860 0.97896 0.96124
Space Group C2 C2 C2
Unit Cell (A˚) a 	 82.86 a 	 82.86 a 	 82.89
b 	 34.35 b 	 34.36 b 	 34.35
c 	 44.29 c 	 44.30 c 	 44.30
 	 115.30  	 115.22  	 115.30
Resolution (A˚) 15–1.40 (1.45–1.4) 15–1.4 (1.45–1.4) 15–1.4 (1.45–1.4)
Observed Reflections 83,520 83,957 86,238
Unique Reflections 21,933 21,953 22,212
Redundancy 3.8 (2.6) 3.8 (2.6) 3.8 (2.8)
Completeness (%) 97.8 (83.3) 97.8 (83.0) 98.9 (90.5)
Rmerge 0.055 (0.231) 0.052 (0.231) 0.058 (0.275)
I/ I 30.8 (6.7) 30.8 (6.2) 29.77 (5.74)
Rfree reflections 914
Rcryst 0.125
Rfree 0.175
Number of atoms
Protein 958
Water 160
Ins(1,3,4,5)P4 28
Wilson B (A˚2) 16.9

B Protein (A˚2) 13.3

B Water (A˚2) 24.4

B Ins(1,3,4,5)P4 (A˚2) 9.1
RMSD from Ideal Geometry
Bond Lengths (A˚) 0.010
Bond Angles () 2.03
Main Chain B (A˚2) 3.16
The values between the parentheses are for the highest-resolution shell. All measured data were included in structure refinement.
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inositide binding PH domains of DAPP1 [13] and TAPP1 [21] thateither Ala or Cys (Figure 4). The binding of PtdIns(3,4)P2
have been crystallized previously. This fragment was subcloned intoor PtdIns(3,4,5)P3 to these mutants is almost completely
the BamH1 restriction site of the Escherichia coli expression vectorlost, confirming the importance of this interaction in
pGEX4T-1. The resultant construct encodes for the bacterial expres-
permitting PKB to bind Ptdins(3,4,5)P3. Mutation of the sion of PKBPH with an N-terminal glutathione-S-transferase
equivalent Arg residue in the PH domain of the Bruton’s (GST) tag.
tyrosine kinase has also been shown to prevent the
interaction with PtdIns(3,4,5)P3 [19]. The corresponding Purification and Crystallization of Native
and Selenomethionine PKBPHmutation in humans causes X-linked agammaglobuli-
E. coli BL21 cells transformed with the pGEX4T-1 vector encodingnaemia, an inherited immune disease [19, 20]. The com-
the expression of GST-PKBPH were grown at 37C in 4 liters ofplete loss of PtdIns(3,4,5)P3 and PtdIns(3,4)P2 binding
Luria Bertani broth with 50 g/ml ampicilin until OD600 reached 0.7.to PKB is also observed when Lys14 (which interacts The expression of GST-PKBPH was induced by the addition ofwith both the D3 and D4 phosphate groups, Figure 1) 250M isopropyl--D-thiogalactopyranoside, and the bacteria were
or Arg86 (which interacts with the D4 phosphate group) then grown for an additional 16 hr at 27C. The cells were harvested
by centrifugation at 3500 g for 15 min, then lysed by resuspensionare mutated to Ala (Figure 4). However, only a slight
in 200 ml buffer A (50 mM Tris/HCl [pH 7.5], 1 mM EGTA, 1 mMreduction in binding is observed for the Asn53Ala mutant
EDTA, 1 mM NaVO4, 10 mM sodium-glycerophosphate, 50 mM NaF,(which interacts with the D3 and D4 phosphates). The
5 mM dithiothreitol) and “complete” proteinase inhibitor cocktailqualitative data from the protein lipid overlay assays
(one tablet per 25 ml; Roche) containing additional DNase (1.5–2
(Figure 4A) are confirmed by a more quantitative activa- mg/ml) and 1 mg/ml lysozyme. The cells were then incubated on
tion study (Figure 4B) in which the ability of PDK1 to ice for 30 min before a final sonication step. The resulting solution
was centrifuged at 14500  g for 30 min to remove residual debrisphosphorylate and activate wild-type and mutant forms
and was passed through a 0.45-m filter. The supernatant wasof PKB is measured in the absence and presence of
incubated for 1 hr at 4C with 4 ml glutathione-Sepharose beadsPtdIns(3,4,5)P3. The results from this study demon-
equilibrated against buffer A. The beads were then washed fourstrate that the mutants of PKB that are unable to inter- times with five column volumes of buffer A and were subsequently
act with PtdIns(3,4,5)P3 (PKB[K14A], PKB[R25A], and washed six times with five column volumes of buffer B (50 mM Tris/
PKB[R86A]) cannot be phosphorylated or activated by HCl [pH 7.5], 0.1 mM EGTA, 0.3 M NaCl, and 5 mM dithiothreitol).
The PKBPH domain was then separated from the GST-tag by incu-PDK1 in the presence of PtdIns(3,4,5)P3. Together, the
bating the glutathione-Sepharose beads conjugated to GST-structure and the binding and activation studies on the
PKBPH in a ratio of 2 units of thrombin to 10 l resin at 4C over-mutants suggest that, in particular, the D3 and D4 phos-
night. The resin was centrifuged and washed four times with 10 mlphates play a key role in enabling PKB to interact spe- buffer B, and the combined supernatants containing PKBPH werecifically with PtdIns(3,4,5)P3 and PtdIns(3,4)P2, whereas applied to a 0.2-ml benzamidine-agarose column to remove the
the D1 phosphate plays only a supporting role. It is thrombin. The eluate was subsequently applied to a 1-ml glutathi-
one-Sepharose column equilibrated in buffer B to remove traceworth noting that, not only in native PKB, but also in
contamination of GST. The supernatant was then concentrated intoall mutants that we generated (Figure 4), PtdIns(3,4)P2
a 4 ml volume and loaded onto a Superdex 75 26/60 gel filtrationand PtdIns(3,4,5)P3 bind with similar affinity, further em-
column that was previously equilibrated against buffer B. The yieldphasizing that the D5 phosphate plays no role in mediat-
obtained was approximately 5 mg PKBPH domain per liter of E.ing the binding of PKBPH to phosphoinositides, in con- coli culture. PKBPH was analyzed by SDS-PAGE and was found
trast to the PH domains of BTK, DAPP1, and GRP1, to be essentially homogeneous. Further analysis by electrospray
mass spectrometry revealed a major single species with a molecularwhere this phosphate is known to be a key determinant
mass of 14842.4, close to the predicted mass of 14752.6 for theof head group binding [13].
PKBPH fragment.
Selenomethionine-substituted protein was prepared by express-
Conclusions ing protein in the methionine auxotrophic strain B834. Cells were
grown overnight in Luria Bertani media and then further amplifiedIn this study, we have defined the key interactions that
in M9 minimal media supplemented with 1 g/l amino acid mix [22]enable Ins(1,3,4,5)P4 to bind PKBPH. We explained why
lacking methionine. Adenine, guanosine, thymine, and uracil werePKB can bind both PtdIns(3,4,5)P3 and PtdIns(3,4)P2 with
added at 5 g/l, FeSO4 was added at 4 mg/l, and ZnCl2 was addedequal affinity, due to absence of any ordered interac-
at 40 mg/ml. The media was then filtered through a 0.22-m filter,
tions with the D5 phosphate. A mutagenesis strategy, and L-selenomethionine was added to a final concentration of 125
rationally designed on the basis of our structure, has mg/l. The cells were then grown to OD600 	 0.7 at 37C, induced
with IPTG as described above, and grown for an additional 16 hrshown that both the phosphates at D3 and D4 contribute
at 27C. Purification and crystallization proceeded as described forthe major share of the binding affinity. We have also
the native protein, and selenium incorporation was verified withshown that PKBPH binds the lipid head group in a
electrospray mass spectrometry, revealing a major single speciesdifferent mode from that observed in other PtdIns(3,4,5)P3 with a molecular mass of 14944, close to the predicted mass of
binding PH domains. 14872 for the selenomethionine-substituted PKBPH fragment.
PKBPH was concentrated to 8.5 mg/ml with a VivaSpin concen-
trator, and the concentration was verified at OD280. The hanging dropExperimental Procedures
vapor diffusion method was used for producing crystals. Hanging
drops were formed by mixing 1 l protein solution with 1 l of aCloning of PKBPH
The phosphatidylinositide (PtdIns) binding pleckstrin homology (PH) mother liquor solution. Selenomethione PKBPH was complexed
with Ins(1,3,4,5)P4 by incubation in a 10:1 molar ratio of ligand todomain of protein kinase B (PKBPH) was amplified by PCR by
using the Hi-fidelity PCR system with the full-length human PKB protein for 30 min on ice. The complex was crystallized using a
mother liquor containing 0.25 M ammonium acetate, 30% PEG 4000,cDNA as the template and the 5 primer 5-GGATCCATGAGCGACG
TGGCTATTGTGAAGGAG-3 and the 3 primer 5-GGATCCTCAGC 0.1 M sodium acetate (pH 4.6). Monoclinic crystals (Table 1) ap-
peared after 2 days and grew to approximately 0.2  0.2  0.3 mmCCGACCGGAAGTCCATCTCCTC-3. This amplified a length of DNA
encoding residues 1–123 of human PKB, with a stop codon immedi- after 4 days. Crystals were frozen in a nitrogen gas stream after
being soaked in 10% 2-methyl-2,4-pentanediol for 30 s.ately after codon 123 that is equivalent in length to the 3-phospho-
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Data Collection, Structure Solution, and Refinement gets of phosphatidylinositol 3-kinase using a novel in vivo assay
in yeast. EMBO J. 17, 5374–5387.A multiwavelength anomalous dispersion (MAD) data set for seleno-
methionine PKBPH-Ins(1,3,4,5)P4 was collected on Station 14.2 at 2. Lemmon, M.A., and Ferguson, K.M. (2000). Signal-dependent
membrane targeting by pleckstrin homology (PH) domains. Bio-the Daresbury Synchrotron Radiation Source with an ADSC Q4 CCD
detector. The temperature of the crystals was maintained at 100K chem. J. 350, 1–18.
3. Brazil, D.P., and Hemmings, B.A. (2001). Ten years of proteinby using a nitrogen cryostream. Data were processed with the HKL
package [23], and the statistics are shown in Table 1. kinase B signalling: a hard Akt to follow. Trends Biochem. Sci.
26, 657–664.The structure of a PKBPH domain bound to Ins(1,3,4,5)P4 was
solved by MAD phasing with a three-wavelength experiment. Calcu- 4. Downward, J. (1998). Mechanisms and consequences of activa-
tion of protein kinase B/Akt. Curr. Opin. Cell Biol. 10, 262–267.lation of an anomalous Patterson with the peak wavelength data
revealed a single 15 peak. Two selenium sites were located and 5. Lawlor, M.A., and Alessi, D.R. (2001). PKB/Akt: a key mediator
of cell proliferation, survival and insulin responses? J. Cell Sci.refined with SOLVE [24], and this refinement resulted in experimental
phases to 1.4 A˚ with a figure of merit of 0.5, yielding a readily 114, 2903–2910.
6. Frech, M., Andjelkovic, M., Ingley, E., Reddy, K.K., Falck, J.R.,interpretable electron density map. Phases were further improved
and Hemmings, B.A. (1997). High affinity binding of inositolby density modification with DM [25], resulting in an electron density
phosphates and phosphoinositides to the Pleckstrin homologymap that showed well-defined density for the protein and the
domain of RAC protein kinase B and their influence on kinaseIns(1,3,4,5)P4 molecule (Figure 1). The map was automatically inter-
activity. J. Biol. Chem. 272, 8474–8481.preted with warpNtrace [26], which built 111 of a possible 123 resi-
7. James, S.R., Downes, C.P., Gigg, R., Grove, S.J.A., Holmes,dues and gave an initial protein model with R 	 0.323 (Rfree 	 0.324).
A.B., and Alessi, D.R. (1996). Specific binding of the Akt-1 pro-Iterative protein building in O [27] together with refinement in CNS
tein kinase to phosphatidylinositol 3,4,5-trisphosphate without[28] and incorporation of Ins(1,3,4,5)P4 improved the model to R 	
subsequent activation. Biochem. J. 315, 709–713.0.277 (Rfree 	 0.289). Refinement was then continued with SHELX-
8. Andjelkovic, M., Alessi, D.R., Meier, R., Fernandez, A., Lamb,97, employing atomic anisotropic B factors and riding hydrogens
N.J.C., Frech, M., Cron, P., Cohen, P., Lucocq, J.M., and Hem-as a last step, and this refinement resulted in the final model with
mings, B.A. (1997). Role of translocation in the activation andR 	 0.125 (Rfree 	 0.175), which encompassed residues 1–113.
function of protein kinase B. J. Biol. Chem. 272, 31515–31524.Figures were made with PyMOL (http://www.pymol.org) and
9. Bellacosa, A., Chan, T.O., Ahmed, N.N., Datta, K., Malstrom, S.,GRASP [29].
Stokoe, D., McCormick, F., Feng, J.N., and Tsichlis, P. (1998).
Akt activation by growth factors is a multiple-step process: theCharacterization of PKB Mutants
role of the PH domain. Oncogene 17, 313–325.The wild-type and mutants of PKB that were used for the lipid
10. Watton, S.J., and Downward, J. (1999). Akt/PKB localisationbinding experiments were expressed in human embryonic kidney
and 3-phosphoinositide generation at sites of epithelial cell-293 cells and were purified as described before [11]. Lipid binding
matrix and cell-cell interaction. Curr. Biol. 9, 433–436.studies were carried out by using the protein-lipid overlay assay
11. Alessi, D.R., Deak, M., Casamayor, A., Caudwell, F.B., Morrice,described previously [30]. Restriction enzyme digests, DNA lig-
N., Norman, D.G., Gaffney, P., Reese, C.B., MacDougall, C.N.,ations, Polymerase Chain Reaction cloning, and site-directed muta-
Harbison, D., et al. (1997). 3-phosphoinositide-dependent pro-genesis were performed by using standard protocols. All DNA con-
tein kinase-1 (PDK1): structural and functional homology withstructs were verified by DNA sequencing (The Sequencing Service,
the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776–789.School of Life Sciences, University of Dundee). All the phosphoinosi-
12. Stephens, L., Anderson K., Stokoe, D., Erdjument-Bromage, H.,tides used in this study were dipalmitoyl derivatives obtained from
Painter, G.F., Holmes, A.B., Gaffney, P.R., Reese, C.B., McCor-Echelon. Hybond-C extra, the pGEX4T-1 vector, Enhanced Chemilu-
mick, F., Tempst, P., et al. (1998). Protein kinase B kinases thatminescence reagent, thrombin protease, and glutathione-Sepha-
mediate phosphatidylinositol 3,4,5-triphosphate-dependentrose were from Amersham Pharmacia Biotech; protease inhibitor
activation of protein kinase B. Science 279, 710–714.tablets were from Roche; Benzamidine-Agarose and monoclonal
13. Ferguson, K.M., Kavran, J.M., Sankaran, V.G., Fournier, E., Isa-anti-glutathione-S-transferase (GST) antibody were from Sigma; and
koff, S.J., Skolnik, E.Y., and Lemmon, M.A. (2000). Structuralthe anti-goat anti-mouse horseradish peroxidase-conjugated sec-
basis for discrimination of 3-phosphoinositides by pleckstrinondary antibody was from Pierce.
homology domains. Mol. Cell 6, 373–384.
14. Hyvonen, M., MacIas, M.J., Nilges, M., Oschkinat, H., Saraste,
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